About Robert Picarel
Robert Picarel is a director of SymKardia and of Nocionix, Inc. SymKardia is developing selective cardiac neuromodulation to treat cardiac arrhythmias.
Experience
This experience comes from Robert Picarel's profile and from SEC filings. For roles taken from filings, the years are when the filings name Robert Picarel in the role, so the role may have started earlier or lasted longer.
Nocionix,Inc. Current
Director
2026 – Present · Westlake, OH
Nocionix develops a nerve-based therapy for people with chronic pain that avoids hormones, surgery, and opioids.
SymKardia, Inc. Current
Director
2026 – Present · Westlake, OH
SymKardia is developing selective cardiac neuromodulation as a new way to treat patients with cardiac arrhythmias.
AB
ABVF Current
Co-founder / Board member / Investor
2022 – Present
TC
TNBT Capital Current
Founder & Chairman
2021 – Present
AK
AKURO Current
Co-founder / Head of Strategy / Investor
2021 – Present
VC
Velvet Consulting
Co-Founder & Chairman
2004 – 2026
CA
Capgemini
Manager
1999 – 2002
NI
Nielsen
Consultant
1996 – 1999
Key Colleagues at Startups
The people Robert Picarel works with at each company, as listed on that company's latest Form D.
Nocionix,Inc. · Form D, Nov 4, 2026
AS
Arun Sridhar
Director
CR
Claudio Rumazza
Executive officer and director
AC
Anthony Caparso
President and director
AC
Alain Garcinuno Collet
Director
JB
James Blouzard
Director
TA
Tony Artiga
Director
SymKardia, Inc. · Form D/A, Oct 28, 2026
AC
Anthony Caparso
President and director
Bruce KenKnight
Chief Executive Officer
Steven Girouard
Executive officer
Jonathan Piccini
Executive officer
Imad Libbus
Chief Scientific Officer
Dwight Skinner
Executive officer
AS
Arun Sridhar
Director
CR
Claudio Rumazza
Director
AC
Alain Garcinuno Collet
Director
JB
James Blouzard
Director